Calderón-Cisneros E, Beltrán-Montoya J, Ávila-Vergara MA, Aragón-Hernández JP, Caldiño-Soto F, Castilla-Zenteno A, García-Espinosa M, Gil-Márquez J, Gudiño-Ruiz EN, Hernández-Rivera C, Loya-Montiel L, Salvador-Domínguez G, Vadillo-Ortega F

Language: Spanish
References: 18
Page: 314-324
PDF size: 256.43 Kb.

ABSTRACT

Background: Induction of labor is a maneuver indicated when there is a greater risk of continuing the pregnancy, than interrupting it. The induction of labor faces new pressures that make it necessary for the doctor to be permanently updated. In recent years, clinical protocols of greater efficiency and safety have been developed, which have made this procedure more accessible.
Objetive: To present an updated consensus and to analyze the different aspects related to the labor induction.
Material and Methods: A Delphi-type of consensus was conducted with participation of active obstetricians and gynecologists specialists from thirteen national institutions. Major clinical-oriented topics of induction of labor were addressed.
Conclusions: To induce labor, it is necessary that at least the following situations coexist: to establish with certainty that the procedure offers the best outcome for the mother and her child, to confirm the gestational age, to make a complete obstetric evaluation and to have the infrastructure Necessary to deal with possible complications. There are several options to induce labor, although in recent years the indication of prostaglandin analogues (misoprostol) has become the most common option worldwide. The specialist must make an individualized evaluation of the patient and the fetus, in order to rule out situations that may endanger the health of any of them. The most common complication of labor induction is tachysystole, which can be complicated by premature placental abruption, uterine rupture and acute fetal distress, requiring urgent attention. Controlled-release vaginal ovules are the only option available to withdraw the stimulus with dinoprostone or misoprostol in the presence of adverse effects.

REFERENCES

1. Souza J, Tuncalp O, Vogel J, Bohren M, Widmer M, Oladapo O, et al. Obstetric transition: the pathway towards ending preventable maternal deaths. Br J Gynecol Obstet. 2014;121(1):1-4.

2. CENETEC. Inducción del trabajo de parto en el segundo nivel de atención México, 2013. [En línea]. Dirección URL: . [Consulta: 25 de septiembre 2015].

3. Souza J, Gulmezoglu A, Vogel J, Carroli G, Lumbiganon P, Qureshi Z, et al. Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study. Lancet 2013;381:1747-55.

4. Instituto Nacional de Perinatología Isidro Espinosa de los Reyes. Evaluación Anual del Cumplimiento de Código de Conducta y Ética 2015.Secretaría de Salud.

5. Reusch L, Feltovich H, Carlson L, Hall G, Campagnola P, Eliceiri K, et al. Nonlinear optical microscopy and ultrasound imaging of human cervical structure. J Biomed Optics 2013;18(3):031110.

6. Gonzalez J, Romero R, Girardi G. Comparison of the mechanisms responsible for cervical remodeling in preterm and term labor. J Reprod Immunol 2013;97(1):112-9.

7. Committee Opinion. ACOG Practice Bulletin. Induction of labor. Obstet Gynecol 2009;114(2):386-97.

8. Hofmeyr G, Gülmezoglu A, Pileggi C. Vaginal misoprostol for cervical ripening and induction of labor. Cochrane Database System Rev 2010;10:CD000941.

9. NICE. Induction of labour London,UK: NICE; 2012. [En línea]. Dirección URL: . [Consulta: septiembre 2015].

10. WHO. WHO recommendations for induction of labour Geneva, Switzerland: WHO; 2011. [En línea]. Dirección URL: . [Consulta septiembre 2015].

11. Leduc D, Biringer A, Lee L, Dy J. SOGC Clinical Parctice Guideline. Induction of labour. J Obstet Gynecol Canada 2013;35(9):S1-S18.

12. Lalor J, Fawole B, Alfirevic Z, Devane D. Biophysical profile for fetal assessment in high risk pregnancies. Cochrabe Database System Rev 2012;2008(1):CD000038.

13. Ministerio de Salud Pública. Guías en Salud Sexual y Reproductiva. Capítulo: Normas de Atención a la Mujer en el Proceso de Parto y Puerperio. Montevideo, Uruguay: Ministerio de Salud Pública; 2008.

14. Yap-Seng C, Lin-Lin S, Sabaratnam A. Misoprostol: A quarter century use, abuse, and creative misuse. Obstet Gynecol Surv 2004;59(2):128-40.

15. Powers B, Wing D, Carr D, Ewert K, Spirito M. Pharmacokinetic profiles of controlled-release hydrogel polymer vaginal inserts containing Misoprostol. J Clin Pharmacol 2008;48:26-34.

16. Gregory S, Anthopolos R, Osgood C, Grotegut C, Miranda M. Association of autism with induced or augmented childbirth in North Carolina Birth Record (1990-1998) and Education Research (1997-2007) databases. JAMA Pediatrics 2013;167(10):959-66.

17. Budden A, Chen L, Henry A. High-dose versus low-dose oxytocin infusion regimens for induction of labour at term. Cochrane Database System Rev 2014;2014(10):CD009701.

18. Alfirevic Z, Keeney E, Dowswell T, Welton N, Dias S, Jones L, et al. Labour induction with prostaglandins: a systematic review and network meta-analysis. Br Med J 2015;350(h217):1-12.